Medicure

Medicure is a pharmaceutical company dedicated to the development and commercialization of cardiovascular therapies for the U.S. market. Medicure's vision is to become the leading cardiovascular drug company in the United States, offering a growing portfolio of products that improve cardiovascular disease outcomes and enhance patients' lives. Medicure is committed to delivering safe, effective, and cost-efficient drugs that benefit patients, healthcare providers, and shareholders.Founded in 1997, Medicure focused on research and development during its first decade. In 2008, the company began transitioning to concentrate on its commercial pharmaceutical business. This new direction has led to significant shareholder value through the sales growth of Aggrastat® (tirofiban hydrochloride), achieving profitability, and pursuing development and acquisition opportunities.